ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,081.85
0.22%
Dow Jones
38,488.33
-0.04%
US Dollar vs MXN
17.05751
0.55%
Brent Oil
87.185
-0.43%
Bitcoin
66,144.91
-0.40%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
24/04/202409:05GlobeNewswire Inc.Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCONASDAQ:REGNRegeneron Pharmaceuticals Inc
24/04/202409:05GlobeNewswire Inc.Volvo Trucks North America Continues ‘Toward Zero’ by Fueling All New Trucks with HVO at the New River Valley Plant
24/04/202409:05Business WireRiemer & Braunstein Announces Promotions
24/04/202409:05Business WireHighField Biopharmaceuticals Announces Two Abstracts Accepted for the 2024 ASCO Annual Meeting
24/04/202409:05Business WireEasyKnock Announces Partnership With Piñata
24/04/202409:05GlobeNewswire Inc.Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual MeetingTSX:MDNAMedicenna Therapeutics Corp
24/04/202409:05GlobeNewswire Inc.Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:HOWLWerewolf Therapeutics Inc
24/04/202409:05Business WireAlliant Insurance Services Welcomes Esther Magner as Vice President and Producer for Employee Benefits Group
24/04/202409:05PR Newswire (US)Duke Energy's annual Impact Report shares progress toward a cleaner tomorrow that includes affordability and reliabilityNYSE:DUKDuke Energy Corp New
24/04/202409:05Business WireBicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
24/04/202409:05PR Newswire (US)Onward Search Wins ClearlyRated's 2024 Best of Staffing Awards
24/04/202409:05PR Newswire (US)IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored StudyNASDAQ:IDYAIDEAYA Biosciences Inc
24/04/202409:04Business WireBayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues
24/04/202409:04PR Newswire (US)BitIRA Launches Self-Service Bitcoin IRA Platform
24/04/202409:03Business WireLegacy Brokerage and Marketing Redefines Brokerage Standards with Innovative Approach
24/04/202409:02GlobeNewswire Inc.Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CHRSCoherus BioSciences Inc
24/04/202409:02PR Newswire (US)Portwest Lights Up Times Square, Celebrating a Decade of Safety
24/04/202409:01Business WireNuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:NUVBPanacea Acquisition Corp
24/04/202409:01Business WireIvanti Appoints New Senior Vice President of Sales in APAC Region
24/04/202409:01PR Newswire (US)SiC-on-Insulator (SiCOI) Film Market worth $1,134 million by 2029 - Exclusive Report by MarketsandMarkets™
24/04/202409:01PR Newswire (US)Generative AI Market to Surpass USD 165.49 Billion by 2031 | SkyQuest Technology
24/04/202409:01PR Newswire (US)Ancestry® makes new record collection available for free to honor the 125,000+ people of Japanese descent unjustly incarcerated during and after World War II
24/04/202409:01PR Newswire (US)Drone Communication Market to Reach $15.8 Billion Globally by 2032 at 21.4% CAGR: Allied Market Research
24/04/202409:01GlobeNewswire Inc.Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
24/04/202409:00Business WireGreat American Insurance Group Announces the Formation of a Dedicated Team to Expand its Embedded Insurance Offerings
24/04/202409:00Business WireMerichem Technologies Enhances Sulfur Treatment Capabilities with Acquisition of Chemical Products Industries
24/04/202409:00Business WireUnCruise Adventures Launches Alaska Season with Unique Itineraries and Multiple Awards
24/04/202409:00GlobeNewswire Inc.TransPerfect Media Acquires Content Lab to Expand Studio Presence in Africa
24/04/202409:00Business WireSOTIO to Present Poster on DUET-01 Clinical Trial at 2024 ASCO Annual Meeting
24/04/202409:00Business Wireathenahealth and the American Council of the Blind Collaborate to Expand Digital Accessibility for athenahealth Patients

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
COIN
SOLUSD
Solana
USOTC
BNPQY
BNP Paribas (QX)
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US30
US 30
PM
XAUUSD
Gold vs US Dollar
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
USOTC
BASFY
BASF (QX)
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados